Trials / Sponsors / Herbert Hurwitz
Herbert Hurwitz
Academic / Other · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2010-03-01 |
| Completed | Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Unspecified Adult Solid Tumor, Protocol Specific, Cancer | Phase 1 | 2009-07-01 |
| Completed | Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus Colorectal Adenocarcinoma | Phase 2 | 2007-10-01 |
| Completed | Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colore Colorectal Cancer | Phase 2 | 2006-01-01 |
| Completed | A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors Solid Tumors | Phase 1 | 2005-09-01 |
| Completed | Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2003-08-01 |